Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630213 · ClinicalTrials.gov registry record · NA
Impact of Vitamin D Supplementation on Cardiac Structure and Function
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,025
- Enrollment target
NCT01630213: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01630213 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,025 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630213, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,025 participants
- Enrollment target
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study (VITAL-Echo) is being conducted among participants in VITAL and will examine whether vitamin D compared to placebo: (1) reduces left ventricular (LV) mass in elderly individuals as measured with 2-dimensional echocardiography and (2) improves LV systolic and diastolic function as measured with tissue Doppler echocardiography.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 + fish oil/fish oil placebo
- DIETARY_SUPPLEMENT Vitamin D3 placebo + fish oil/fish oil placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2010-07-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01630213
The ClinicalTrials.gov registry entry for NCT01630213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,025 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 + fish oil/fish oil placebo is the first listed.
NCT01630213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01630213 about?
NCT01630213 is a clinical study titled "Impact of Vitamin D Supplementation on Cardiac Structure and Function". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 20,000 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or fish oil (1 gram of omega-3 fatty acids) reduces the risk of developing cancer, heart disease, and strok...
What is the current status of trial NCT01630213?
This trial is currently completed. It is a NA study. The enrollment target is 1,025 participants. The study started on 2010-07-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT01630213?
The interventions under investigation include: Vitamin D3 + fish oil/fish oil placebo (DIETARY_SUPPLEMENT), Vitamin D3 placebo + fish oil/fish oil placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01630213?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.